| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/01/2008 | CN101273966A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same |
| 10/01/2008 | CN101273965A Temperature controlled sustained-release injection containing anti-cancer medicine |
| 10/01/2008 | CN101273963A Temperature controlled sustained-release injection containing steroids anti-cancer drugs |
| 10/01/2008 | CN101273962A Temperature controlled sustained-release injection comprising alkyl agent and method for preparing the same |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422139C 氨基链烷醇衍生物 Amino alkanol derivative |
| 10/01/2008 | CN100421731C Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/01/2008 | CN100421727C Methods |
| 10/01/2008 | CN100421674C Synergistic antimicrobial ophthalmic and dermatologic preparations |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
| 10/01/2008 | CN100421661C Method of inducing cancer cell death and tumor regression |
| 10/01/2008 | CN100421659C Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 10/01/2008 | CN100421653C Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 10/01/2008 | CN100421565C Oil/fat composition |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429614 Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus |
| 09/30/2008 | US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429580 Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/30/2008 | US7429560 Ketoamide inhibitors in chronic nerve disease |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429449 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
| 09/30/2008 | US7429394 Core comprising a potassium binding polymer, shell component comprising a crosslinked amine functional polymer alkylated with hydrophobic agent(s); treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency |
| 09/30/2008 | US7429387 Administering neurotoxin |
| 09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
| 09/30/2008 | CA2505933C Use of botulinum toxin for treating urinary incontinence |
| 09/30/2008 | CA2488300C Combination of voriconazole and an antifungal cyp2c19 inhibitor |
| 09/30/2008 | CA2377762C Sulfonamidomethyl phosphonate inhibitors of .beta.-lactamase |
| 09/30/2008 | CA2374763C Composition for improving skin lipid barrier function |
| 09/30/2008 | CA2263425C Pharmaceutical agent containing rho kinase inhibitor |
| 09/25/2008 | WO2008116195A2 Compositions comprising an sglt2 ingibitor for treating obesity |
| 09/25/2008 | WO2008115959A1 Hypoxia inducible factor inducer and methods for using the same |
| 09/25/2008 | WO2008115413A1 Aromatase inhibitors for the treatment of mastalgia |
| 09/25/2008 | WO2008114876A1 A method of treating malignant mesothelioma |
| 09/25/2008 | WO2008113862A2 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 09/25/2008 | WO2008113149A2 Observations where certain claims were found unsearchable |
| 09/25/2008 | WO2008092103A3 Combination cancer treatments comprising elsamitrucin and other agents |
| 09/25/2008 | WO2008086128A3 Aminopyrazole kinase inhibitors |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234316 Quinuclidine Amide Derivatives |
| 09/25/2008 | US20080234296 Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists |
| 09/25/2008 | US20080234288 Using compounds such as {3-[(2-Acetylamino-benzooxazole-6-sulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid thiazol-5-ylmethyl ester; HCV infections |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs |
| 09/25/2008 | US20080233104 Probiotic, lactic acid-producing bacteria and uses thereof |
| 09/25/2008 | US20080233083 Methods and Compositions for Vaccination of Animals with Prrsv Antigens with Improved Immunogenicity |
| 09/25/2008 | US20080233081 Pro-angiogenic peptides |
| 09/25/2008 | US20080233073 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia |
| 09/25/2008 | DE59410246C5 Pharmazeutische formulierung zur prophylaxe bzw. vorbehandlung einer vergiftung durch phosphororganische cholinesterasehemmer Pharmaceutical formulation for the prophylaxis or pre-treatment of poisoning by organophosphorus cholinesterase inhibitors |
| 09/25/2008 | CA2684985A1 Combination of a narcotic and a non-narcotic analgesic |
| 09/25/2008 | CA2681185A1 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 09/25/2008 | CA2680368A1 A method of treating malignant mesothelioma |
| 09/24/2008 | EP1972638A1 Remedies for juvenile chronic arthritis and related diseases |
| 09/24/2008 | EP1972344A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 09/24/2008 | EP1971371A2 Cancer therapies and pharmaceutical compositions used therein |
| 09/24/2008 | EP1971370A1 Oral s-adenosylmethionine compositions |
| 09/24/2008 | EP1971368A2 Compositions and methods for treating thrombocytopenia |
| 09/24/2008 | EP1971341A1 Use of morpholino compounds for the treatment of halitosis |
| 09/24/2008 | EP1971334A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1496836B1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 09/24/2008 | EP1485463B1 Lactobacillus strains |
| 09/24/2008 | EP1383578B1 Single dose aromatase inhibitor for treating infertility |
| 09/24/2008 | CN101272806A 过早排卵抑制剂 Premature ovulation inhibitors |
| 09/24/2008 | CN101272805A Pharmaceutical composition containing PPAR gamma agonist |
| 09/24/2008 | CN101272790A Stable protease composition |
| 09/24/2008 | CN101272787A Use of opioid receptor antagonists |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/24/2008 | CN101269212A Gargle capable of being swallowed |
| 09/24/2008 | CN101269052A Oral instant quick-effective emulsion membrane and three-dimensional printing preparation method |
| 09/24/2008 | CN101269013A Method for preparing polymer microsphere |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427629 Immunostimulatory compositions and methods of stimulating an immune response |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | US7427609 Menopause; hormone replacement therapy; controlling dosage |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427602 nucleic acid-matrix materials are created such that they maintain a defined space, allowing cellular migration, transfection and proliferation to occur in a controlled manner; in vivo cell transfection and gene expression |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427485 Method for classification of anti-psychotic drugs |
| 09/23/2008 | US7427415 Implantation of encapsulated biological materials for treating diseases |
| 09/23/2008 | US7427402 for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis; treatment to prevent such skin inflammatory disorders using antagonists of IL- 17A, IL-17F, IL-19, and/or IL-23 |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2437820C Endomural therapy |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |